Submission Details
| 510(k) Number | K202525 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 01, 2020 |
| Decision Date | May 19, 2022 |
| Days to Decision | 625 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K202525 is an FDA 510(k) clearance for the Alinity i STAT High Sensitivity Troponin-I, a Immunoassay Method, Troponin Subunit (Class II — Special Controls, product code MMI), submitted by Abbott Laboratories Diagnostics Division (Abbott Park, US). The FDA issued a Cleared decision on May 19, 2022, 625 days after receiving the submission on September 1, 2020. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1215.
| 510(k) Number | K202525 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 01, 2020 |
| Decision Date | May 19, 2022 |
| Days to Decision | 625 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | MMI — Immunoassay Method, Troponin Subunit |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1215 |